Universities and companies that turn discoveries into medicines in Seattle have searched for “safe harbor” from the White ...

We unpack the full scope of the U.S. budget cuts, from canceled clinical trials and stalled drug approvals to mass layoffs ...

More than a hundred experts in molecular simulation have published a paper in the journal Nature Methods calling for a paradigm shift in molecular dynamics data management.

Vir Biotechnology, Inc. operates as a clinical-stage immunology company that focuses on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases.

Cancer research in the U.S. doesn't rely on a single institution or funding stream − it's a complex ecosystem made up of ...

Commissioners visit UD-based NIIMBL, where public-private partnerships promote innovation, workforce development ...

Since 1971, the US has led the world in funding cancer research and developing new treatments that have driven down death ...

Kendall Square has become a hub of biotech innovation and a popular location for up and coming life sciences firms. Now, a ...

Galaxy Research proposed a new Solana voting system called Multiple Election Stake-Weight Aggregation (MESA). The firm noted that the new proposal will allow validators to vote on multiple deflation ...

The biotech granted Avenzo Therapeutics ex-China ... In addition, Ollin is funding research by a professor of ophthalmology at Duke University. The professor, who studies glaucoma, received ...

NSF employees say that DOGE has directed hundreds of research proposals approved during a multi-step review process — but not yet finalized — be sent back to NSF programme officers ...

This cycle has attracted 140 innovative research proposals, marking a 47 percent increase from the Fifth Cycle. Pre-proposal submissions opened on 28th January 2025, coinciding with the 7th ...